[COLL] Collegium Pharmaceutical, Inc.

Overview

Type of security:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 16.35 Change: 0.79 (5.08%)
Ext. hours: Change: 0 (0%)

chart COLL

Refresh chart

Technical Data
High 52 week29.21 Low 52 week13.58 Last close15.22 Last change-1.87%
RSI44.79 Average true range0.73 Simple moving average 20 days1.16% Simple moving average 50 days-3.83%
Simple moving average 200 days-17.81%
Performance Data
Performance Week2.91% Performance Month-0.2% Performance Quart-11.25% Performance Half-9.78%
Performance Year-36.34% Performance Year-to-date-11.36% Volatility daily2.59% Volatility weekly5.79%
Volatility monthly11.88% Volatility yearly41.14% New High New Low

News

2019-03-25 09:00:01 | Collegium Pharmaceutical COLL Upgraded to Buy: What Does It Mean for the Stock?

2019-03-06 23:49:36 | Assertio Therapeutics, Inc ASRT Q4 2018 Earnings Conference Call Transcript

2019-02-28 03:03:01 | Edited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMT

2019-02-27 19:14:44 | Collegium Pharmaceutical Inc COLL Q4 2018 Earnings Conference Call Transcript

2019-02-27 16:01:00 | Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results

2019-02-20 10:31:03 | Collegium Pharmaceutical COLL May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-02-15 09:30:02 | ASRT or COLL: Which Is the Better Value Stock Right Now?

2019-02-13 08:40:19 | Collegium to Host Conference Call to Discuss Fourth Quarter 2018 Financial Results and Provide Corporate Update

2019-02-12 14:03:26 | Breakeven On The Horizon For Collegium Pharmaceutical, Inc. NASDAQ:COLL

2019-01-30 09:30:02 | ASRT vs. COLL: Which Stock Should Value Investors Buy Now?

2019-01-17 07:20:00 | Report: Developing Opportunities within Enterprise Products Partners, Antero Midstream Partners LP, Integrated Device Technology, Collegium Pharmaceutical, GAIN Capital, and United Technologies — Future Expectations, Projections Moving into 2019

2019-01-14 09:30:02 | ASRT vs. COLL: Which Stock Should Value Investors Buy Now?

2019-01-07 08:00:00 | Collegium Provides Full-Year 2019 Financial Guidance

2018-12-19 23:43:22 | Do Hedge Funds Love Collegium Pharmaceutical Inc COLL?

2018-12-11 14:31:04 | How Financially Strong Is Collegium Pharmaceutical, Inc. NASDAQ:COLL?

2018-11-26 16:44:34 | Collegium Pharmaceutical, Inc. NASDAQ:COLL: Are Hedge Funds Right About This Stock?

2018-11-12 07:24:14 | Collegium to Present at Upcoming Investor Conferences

2018-11-08 21:16:22 | Edited Transcript of COLL earnings conference call or presentation 8-Nov-18 9:30pm GMT

2018-11-08 19:25:12 | Collegium Pharmaceutical COLL Reports Q3 Loss, Lags Revenue Estimates

2018-11-08 18:21:29 | Collegium Pharmaceutical: 3Q Earnings Snapshot

2018-11-08 16:05:00 | Collegium Reports Third Quarter Financial Results

2018-11-08 08:04:01 | Collegium Pharmaceutical Q3 Earnings Preview

2018-11-01 11:28:03 | Collegium Pharmaceutical COLL May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2018-10-29 08:00:00 | Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER

2018-10-18 08:00:00 | Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular — New Horizons, Emerging Trends, and Upcoming Developments

2018-10-17 08:30:43 | Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update

2018-09-28 14:16:49 | Collegium to Present at Upcoming Investor Conference

2018-09-04 10:01:14 | Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting

2018-08-31 13:27:06 | Surge in Xtampza Sales Bodes Well for Collegium Pharmaceutical

2018-08-31 13:27:06 | What Collegium Pharmaceutical’s Valuation Trend Indicates

2018-08-31 13:27:04 | How Is Insys Therapeutics Positioned in H2 2018?

2018-08-24 07:30:00 | Report: Exploring Fundamental Drivers Behind Fiesta Restaurant Group, Emerge Energy Services LP, Collegium Pharmaceutical, Cutera, Resources Connection, and Spark Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

2018-08-23 23:45:35 | Edited Transcript of COLL earnings conference call or presentation 8-Aug-18 8:30pm GMT

2018-08-08 19:30:11 | Collegium Pharmaceutical COLL Reports Q2 Loss, Tops Revenue Estimates

2018-08-08 16:01:00 | Collegium Reports Second Quarter Financial Results and Provides Corporate Update

2018-08-08 14:30:00 | Collegium Pharmaceutical, Inc. to Host Earnings Call

2018-08-08 10:16:17 | Q2 Earnings Preview Collegium Pharmaceutical

2018-07-31 07:10:00 | Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks

2018-07-20 13:06:42 | Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update

2018-07-10 07:30:00 | Collegium Announces Promotion of Scott Dreyer to CCO

2018-06-28 07:50:00 | Free Research Reports on Catalent and Three More Generic Drugs Stocks

2018-06-26 14:55:42 | Is Collegium Pharmaceutical Inc NASDAQ:COLL A Financially Sound Company?

2018-06-18 07:40:00 | New Research: Key Drivers of Growth for Outfront Media, Enel Chile, Banc of California, Northern Dynasty Minerals, Collegium Pharmaceutical, and Petroleo Brasileiro S.A. - Petrobras — Factors of Influence, Major Initiatives and Sustained Production

2018-06-12 16:10:06 | Cantor Fitzgerald Out Bullish On Collegium As 'Leading Company' In Pain Management

2018-06-04 16:01:00 | Collegium Announces CEO Succession

2018-05-30 16:01:00 | Collegium to Present at Upcoming Investor Conferences

2018-05-11 07:00:00 | Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks

2018-05-10 17:40:00 | Why Depomed Inc.'s Shares Soared 23.2% Higher

2018-05-09 21:56:29 | Edited Transcript of COLL earnings conference call or presentation 9-May-18 8:30pm GMT

2018-05-09 16:14:13 | Collegium Pharmaceutical: 1Q Earnings Snapshot